We are live on ! Find out more
TECH icon

Bio-Techne

418 hedge funds and large institutions have $8.99B invested in Bio-Techne in 2020 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 155 increasing their positions, 143 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 27

7% more funds holding

Funds holding: 392418 (+26)

8% more repeat investments, than reductions

Existing positions increased: 155 | Existing positions reduced: 143

5.27% less ownership

Funds ownership: 382.35%377.08% (-5.3%)

7% less capital invested

Capital invested by funds: $9.65B → $8.99B (-$655M)

18% less call options, than puts

Call options by funds: $18.1M | Put options by funds: $22M

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
418
Holders Change
+26
Holders Change %
+6.63%
% of All Funds
8.43%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.08%
New
54
Increased
155
Reduced
143
Closed
27
Calls
$18.1M
Puts
$22M
Net Calls
-$3.87M
Net Calls Change
-$20.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
101
Credit Suisse
Switzerland
$8.75M -$7.02M -107,960 -43%
Citigroup
102
Citigroup
New York
$8.63M +$2.79M +42,952 +45%
NC
103
Nicholas Company
Wisconsin
$8.41M
Morgan Stanley
104
Morgan Stanley
New York
$8.31M -$521K -8,012 -6%
SW
105
SVB Wealth
Massachusetts
$8.1M +$8.51M +130,796 New
FWIA
106
Fort Washington Investment Advisors
Ohio
$7.99M -$124K -1,912 -1%
Nordea Investment Management
107
Nordea Investment Management
Sweden
$7.91M -$8.11M -124,684 -50%
Ensign Peak Advisors
108
Ensign Peak Advisors
Utah
$7.35M +$390K +6,000 +5%
AACP
109
Advantage Alpha Capital Partners
California
$7.27M +$5.49M +84,396 +256%
SRC
110
Stone Run Capital
New York
$7.04M +$19.5K +300 +0.3%
State of New Jersey Common Pension Fund D
111
State of New Jersey Common Pension Fund D
New Jersey
$6.95M -$71K -1,092 -1%
BFS
112
Bradley Foster & Sargent
Connecticut
$6.65M +$6.98M +107,364 New
Marshall Wace
113
Marshall Wace
United Kingdom
$6.64M +$6.98M +107,232 New
Baird Financial Group
114
Baird Financial Group
Wisconsin
$6.59M +$988K +15,184 +17%
TCM
115
Tygh Capital Management
Oregon
$6.3M +$119K +1,836 +2%
AG
116
Aperio Group
California
$6.1M -$12K -184 -0.2%
Qube Research & Technologies (QRT)
117
Qube Research & Technologies (QRT)
United Kingdom
$6M +$801K +12,312 +15%
SOADOR
118
State of Alaska Department of Revenue
Alaska
$5.89M +$2.2M +33,752 +55%
OCM
119
Osterweis Capital Management
California
$5.8M +$588K +9,040 +11%
Victory Capital Management
120
Victory Capital Management
Texas
$5.76M +$375K +5,764 +7%
Natixis Advisors
121
Natixis Advisors
Massachusetts
$5.72M -$498K -7,656 -8%
PI
122
PEAK6 Investments
Illinois
$5.62M +$4.88M +74,960 +475%
MIM
123
MetLife Investment Management
New Jersey
$5.47M -$163K -2,508 -3%
CRC
124
Curi RMB Capital
Illinois
$5.43M +$815K +12,536 +17%
VOYA Investment Management
125
VOYA Investment Management
Georgia
$5.25M -$508K -7,804 -8%

TECH Hedge Fund Activity: Q3 2020 in Review

418 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2020, worth a combined $8.99B — down 6.8% from $9.65B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new TECH positions and 27 closed out — a net gain of 27 holders — while 155 added to existing stakes and 143 trimmed.

The largest buyer was Ownership Capital B.V., adding an estimated $62.3M. The largest seller was Wellington Management Group, cutting an estimated $99.8M.

  • 418 institutional investors held Bio-Techne (TECH) as of Q3 2020, up from 392 in Q2 2020.
  • Funds reported $8.99B of Bio-Techne stock for Q3 2020, down 6.8% quarter-over-quarter.
  • 54 funds opened new Bio-Techne positions in Q3 2020 and 27 closed out, a net change of +27 holders.
  • The largest Bio-Techne buyer in Q3 2020 was Ownership Capital B.V., an estimated $62.3M added.
  • The largest Bio-Techne seller in Q3 2020 was Wellington Management Group, an estimated $99.8M sold.

Based on aggregated 13F filings for Q3 2020.